<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01204931</url>
  </required_header>
  <id_info>
    <org_study_id>GERD SISAP</org_study_id>
    <nct_id>NCT01204931</nct_id>
  </id_info>
  <brief_title>Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?</brief_title>
  <official_title>Can We Predict Who Has GERD? Systematic Evaluation of Role of pH Monitoring and the Specific Physiologic pH Parameters in Defining GERD, Bravo, Impedence and SISAP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroesophageal reflux disease (GERD) is currently defined as &quot;a condition which develops
      when the reflux of stomach contents causes troublesome symptoms and/or complications&quot;.
      Doctors often diagnose and treat GERD based on symptoms of heartburn and regurgitation. In
      recent years, the prevalence of partial or non-response to Proton Pump Inhibitors (PPI) has
      increased resulting in diagnostic testing with esophagogastroduodenoscopy (EGD) or ambulatory
      pH monitoring. Most patients do not have endoscopic evidence for reflux. Thus, in this group
      pH monitoring has emerged as an important physiologic test to determine the degree of
      esophageal acid exposure and to assess the association between patients' persistent symptoms
      and acid reflux events. The aims of this study are to assess the sensitivity and specificity
      of symptom associated indices and determine the best parameter for predicting GERD from a
      list of conventional pH measurement findings.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom Index (SI) and Symptom Associated Probability (SAP)</measure>
    <time_frame>Following esophagogastroduodenoscopy (EGD) and 48-hr-wireless pH monitoring</time_frame>
    <description>Assess the sensitivity and specificity of symptom association indices (SI and SAP)regarding gastroesophageal reflux disease (GERD)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Predicting gastroesophageal reflux disease (GERD)</measure>
    <time_frame>Following esophagogastroduodenoscopy (EGD) and 48-hr-wireless pH monitoring</time_frame>
    <description>Determine the best parameter for predicting gastroesophageal reflux disease (GERD) from a list of conventional pH measurement findings.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">254</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Gastroesophageal Reflux Disease (GERD) Cases</arm_group_label>
    <description>Erosive disease - presence of esophageal mucosal injuries documented endoscopically.
Non-erosive disease - normal esophagogastroduodenoscopy with symptoms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>normal subjects without symptoms of gastroesophageal reflux disease (GERD)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects presenting to Vanderbilt University Medical Center Gastroenterology
        outpatient clinic with symptoms consistent with gastroesophageal reflux disease (GERD)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects ages 18 or older

          -  Presenting to the Vanderbilt GI outpatient clinic with symptoms of GERD

          -  Undergoing upper endoscopy and wireless pH monitoring (standard of care)

          -  Erosive disease: presence of esophageal mucosal injuries documented

          -  Non-erosive disease: normal esophagogastroduodenoscopy (EGD) with symptoms

          -  Control group: normal subjects without symptoms of GERD

        Exclusion Criteria:

          -  Anti-reflux therapy within 7 days prior to the pH study

          -  Previous neck, esophagus, or stomach surgery

          -  Major motility disorders

          -  Previous neck, esophagus, or stomach cancer or radiations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Vaezi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center GI Outpatient Clinic</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2010</study_first_submitted>
  <study_first_submitted_qc>September 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2010</study_first_posted>
  <last_update_submitted>January 19, 2016</last_update_submitted>
  <last_update_submitted_qc>January 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Michael Vaezi</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>reflux</keyword>
  <keyword>gastroesophageal reflux disease</keyword>
  <keyword>GERD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

